In contrast to neurodegerative ailments and cancer, the contribution of TG2 activity to celiac sprue pathogenesis continues to be quite well established. The deamidation of specific glutamine residues targeted by TG2 in gluten peptides has actually been revealed to improve peptide binding towards th